Scienture Holdings, Inc.
SCNX
$0.40
-$0.01-1.46%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -417.70% | 809.24% | -- | -- | -58.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -417.70% | 809.24% | -- | -- | -58.74% |
| Cost of Revenue | 49.30% | -74.75% | -- | -- | -79.27% |
| Gross Profit | -8,807.14% | 14,633.33% | -- | -- | 102.46% |
| SG&A Expenses | -21.42% | 112.06% | 188.59% | -45.43% | 51.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.04% | 38.98% | 240.59% | -34.80% | 79.14% |
| Operating Income | 25.16% | -24.68% | -244.85% | 34.98% | -87.02% |
| Income Before Tax | -310.45% | -13.31% | -313.65% | 53.81% | -45.18% |
| Income Tax Expenses | -273.30% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -313.37% | -13.31% | -313.65% | 53.81% | -34.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 94.56% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -292.59% | -13.31% | -266.46% | -114.42% | 38.60% |
| EBIT | 25.16% | -24.68% | -244.85% | 34.98% | -87.02% |
| EBITDA | 35.94% | -24.71% | -244.93% | 34.99% | -195.16% |
| EPS Basic | -83.14% | 85.81% | 63.56% | -101.59% | 93.40% |
| Normalized Basic EPS | 63.65% | 85.25% | 61.22% | 94.78% | 80.05% |
| EPS Diluted | -82.68% | 85.81% | 63.32% | -101.61% | 93.38% |
| Normalized Diluted EPS | 63.65% | 85.25% | 61.22% | 94.78% | 80.05% |
| Average Basic Shares Outstanding | 114.36% | 698.62% | 905.57% | 809.12% | 830.10% |
| Average Diluted Shares Outstanding | 114.36% | 698.62% | 905.57% | 809.12% | 830.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |